Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Cash from Operations (2016 - 2025)

Traws Pharma's Cash from Operations history spans 14 years, with the latest figure at 2758000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 2758000.0 for Q4 2025, up 31.73% from a year ago — trailing twelve months through Dec 2025 was 18185000.0 (up 38.96% YoY), and the annual figure for FY2025 was 18185000.0, up 38.96%.
  • Cash from Operations for Q4 2025 was 2758000.0 at Traws Pharma, up from 4011000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 2758000.0 in Q4 2025 to a low of 11476000.0 in Q3 2024.
  • The 5-year median for Cash from Operations is 4365500.0 (2021), against an average of 5084500.0.
  • The sharpest move saw Cash from Operations plummeted 156.79% in 2024, then surged 65.05% in 2025.
  • Year by year, Cash from Operations stood at 4265000.0 in 2021, then grew by 8.93% to 3884000.0 in 2022, then dropped by 14.06% to 4430000.0 in 2023, then increased by 8.8% to 4040000.0 in 2024, then surged by 31.73% to 2758000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 2758000.0, 4011000.0, and 5979000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.